Enzo Biochem (NYSE: ENZ)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | ||||||
REV | 26.222M |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.030 | ||||||
REV | 34.046M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Enzo Biochem (NYSE: ENZ) through any online brokerage.
Other companies in Enzo Biochem’s space includes: Sema4 Holdings (NASDAQ:SMFR), Aveanna Healthcare Hldgs (NASDAQ:AVAH), ATI Physical Therapy (NYSE:ATIP), Novo Integrated Sciences (NASDAQ:NVOS) and Talkspace (NASDAQ:TALK).
The latest price target for Enzo Biochem (NYSE: ENZ) was reported by Craig-Hallum on Tuesday, February 4, 2014. The analyst firm set a price target for 5.50 expecting ENZ to rise to within 12 months (a possible 169.61% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Enzo Biochem (NYSE: ENZ) is $2.04 last updated Today at June 27, 2022, 4:45 PM UTC.
There are no upcoming dividends for Enzo Biochem.
Enzo Biochem’s Q3 earnings are confirmed for Thursday, June 9, 2022.
There is no upcoming split for Enzo Biochem.
Enzo Biochem is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.